FORWARD PHARMA A/S: Diferență între versiuni
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei FORWARD PHARMA A/S listata cu simbolul US.FWP ==Descriere companie== Forward Pharma A/S (forward-pharma.com) is a Denmark-based bio-pharmaceutical company. It is developing a proprietary formulation of dimethyl fumarate (DMF), for the treatment of multiple sclerosis (MS) and other inflammatory and neurological indications. DMF is an immunomodulator that can be used as a therapeutic to improve the health of patients with MS and immune disorders .The...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| (Nu s-a afișat o versiune intermediară efectuată de același utilizator) | |||
| Linia 1: | Linia 1: | ||
Pagina dedicata companiei FORWARD PHARMA A/S listata cu simbolul US.FWP | Pagina dedicata companiei FORWARD [[PHARMA]] A/S listata cu simbolul US.FWP | ||
==Descriere companie== | ==Descriere companie== | ||
Forward Pharma A/S (forward-pharma.com) is a Denmark-based bio-pharmaceutical company. It is developing a proprietary formulation of dimethyl fumarate (DMF), for the treatment of multiple sclerosis (MS) and other inflammatory and neurological indications. DMF is an immunomodulator that can be used as a therapeutic to improve the health of patients with MS and immune disorders .The Company is headquartered in Copenhagen, Denmark. | Forward Pharma A/S (forward-pharma.com) is a Denmark-based [[BIO|bio]]-pharmaceutical company. It is developing a proprietary formulation of dimethyl fumarate (DMF), for the treatment of multiple sclerosis (MS) and other inflammatory and neurological indications. DMF is an immunomodulator that can be used as a therapeutic to improve the health of patients with MS and immune disorders .The Company is headquartered in Copenhagen, Denmark. | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||
Versiunea curentă din 26 noiembrie 2024 00:24
Pagina dedicata companiei FORWARD PHARMA A/S listata cu simbolul US.FWP
Descriere companieModificare
Forward Pharma A/S (forward-pharma.com) is a Denmark-based bio-pharmaceutical company. It is developing a proprietary formulation of dimethyl fumarate (DMF), for the treatment of multiple sclerosis (MS) and other inflammatory and neurological indications. DMF is an immunomodulator that can be used as a therapeutic to improve the health of patients with MS and immune disorders .The Company is headquartered in Copenhagen, Denmark.
Grafic actiuni companieModificare